Norges Bank Neogenomics Inc Transaction History

Norges Bank

$716 Trillion
Q3 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.01 - $15.77 $7.89 Million - $9.56 Million	606,341 New	606,341 $8.41 Million
Q4 2023 Feb 09, 2024	BUY	$11.67 - $20.73 $10.5 Million - $18.6 Million	896,885 New	896,885 $14.5 Million
Q3 2023 Nov 13, 2024	BUY	$12.15 - $17.85 $11.6 Million - $17.1 Million	956,905 New	956,905 $11.8 Million
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $14.4 Million - $21.2 Million	-1,186,214 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$14.1 - $19.83 $7.32 Million - $10.3 Million	519,208 Added 85.63%	1,125,549 $18.1 Million
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $15 Million - $21.1 Million	-1,066,297 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$9.09 - $19.45 $10.4 Million - $22.3 Million	1,146,221 New	1,146,221 $20 Million
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $9.14 Million - $17.1 Million	1,416,714 New	1,416,714 $13.1 Million
Q3 2022 Nov 13, 2023	BUY	$7.86 - $12.91 $9.32 Million - $15.3 Million	1,186,214 New	1,186,214 $10.2 Million
Q2 2022 Aug 14, 2023	BUY	$7.06 - $13.97 $7.53 Million - $14.9 Million	1,066,297 New	1,066,297 $8.69 Million
Q1 2022 May 12, 2023	SELL	$12.15 - $35.28 $7.26 Million - $21.1 Million	-597,379 Reduced 42.17%	819,335 $9.95 Million
Q1 2022 May 09, 2022	SELL	$12.15 - $35.28 $9.95 Million - $28.9 Million	-819,335 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$30.49 - $48.49 $25 Million - $39.7 Million	819,335 New	819,335 $28 Million
Q3 2021 Nov 14, 2022	BUY	$41.66 - $52.52 $32 Million - $40.4 Million	768,878 New	768,878 $37.1 Million
Q3 2021 Nov 05, 2021	SELL	$41.66 - $52.52 $33.7 Million - $42.5 Million	-809,280 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$36.62 - $51.69 $29.6 Million - $41.8 Million	809,280 New	809,280 $36.6 Million
Q2 2021 Aug 10, 2021	SELL	$36.62 - $51.69 $33.4 Million - $47.1 Million	-911,813 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$41.56 - $59.88 $37.9 Million - $54.6 Million	911,813 New	911,813 $44 Million
Q1 2021 May 07, 2021	SELL	$41.56 - $59.88 $39.2 Million - $56.5 Million	-943,690 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$36.08 - $56.47 $34 Million - $53.3 Million	943,690 New	943,690 $50.8 Million
Q4 2020 Feb 10, 2021	SELL	$36.08 - $56.47 $31.5 Million - $49.3 Million	-873,626 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$33.26 - $40.48 $29.1 Million - $35.4 Million	873,626 New	873,626 $32.2 Million
Q3 2020 Nov 10, 2020	SELL	$33.26 - $40.48 $28 Million - $34 Million	-841,140 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$24.21 - $31.02 $20.4 Million - $26.1 Million	841,140 New	841,140 $26.1 Million
Q2 2020 Aug 07, 2020	SELL	$24.21 - $31.02 $21.3 Million - $27.3 Million	-879,259 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$20.5 - $34.53 $18 Million - $30.4 Million	879,259 New	879,259 $24.3 Million
Q1 2020 May 08, 2020	SELL	$20.5 - $34.53 $17.3 Million - $29.1 Million	-844,190 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$18.96 - $29.84 $16 Million - $25.2 Million	844,190 New	844,190 $24.7 Million
Q4 2019 Feb 12, 2020	SELL	$18.96 - $29.84 $5.97 Million - $9.4 Million	-314,974 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$19.12 - $26.24 $6.02 Million - $8.26 Million	314,974 New	314,974 $6.02 Million

Others Institutions Holding NEO

# of Institutions

291

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$285 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$204 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$99.9 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$95.7 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$94.9 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account